VA
BIIB icon

VestGen Advisors’s Biogen BIIB Stock Holding History

VestGen Advisors’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$281K Sell
1,302
-360
-22% -$68.9K 0.01% 872
2026
Q1 		$331K Sell
1,662
-5,222
-76% -$962K 0.01% 804
2025
Q4 		$1.21M Buy
+6,884
New +$1.12M 0.05% 323

Other funds holding BIIB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

VestGen Advisors's BIIB Position: Q2 2026 in Review

VestGen Advisors reduced its Biogen (BIIB) stake by 22% in Q2 2026, selling an estimated $68.9K and leaving 1,302 shares worth $281K. The position accounts for 0.01% of the portfolio, ranked #872.

VestGen Advisors first reported a position in BIIB in Q4 2025 and has held it in 3 quarters since. The position peaked at $1.21M in Q4 2025. 1,038 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.

  • VestGen Advisors held 1,302 shares of Biogen worth $281K as of Q2 2026.
  • VestGen Advisors sold 360 Biogen shares in Q2 2026, an estimated $68.9K.
  • Biogen made up 0.01% of VestGen Advisors's portfolio in Q2 2026, its #872 holding.
  • VestGen Advisors first reported a position in Biogen in Q4 2025 and has held it in 3 quarters since.
  • VestGen Advisors's Biogen position peaked at $1.21M in Q4 2025.
  • 1,038 funds tracked by Wall St. Rank held Biogen as of Q2 2026.

Based on VestGen Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.